Uncategorized

August 24, 2022 | Dr. Laurie Deerfield

This presentation will assist prescribers in their conceptualization and understanding of different diagnostic categories and ways psychiatric presentations may overlap to guide their choice of agents to treat complex medical psychiatric and substance issues appropriately without exacerbating other comorbid issues. Topics will include the how fentanyl influences those decisions, tips on reading confirmation substance testing, and ways to avoid precipitated withdrawal and the phenomenon known collectively as “restless leg syndrome.” Topics will include treating substance use disorders and anxiety, depression, and bipolar spectrums as well as depressive disorder sub types among others as time allows.

…

…

November 2, 2022 | Elisabeth Mock, MD, MPH and Noah Nesin, MD
What are the best actions to take when patients with chronic pain in a community suddenly lose their provider? Patients on high dose opioids often have difficulty finding new providers. What resources are available to support prescribers in such a transition?

October 11, 2022 | Nick Piotrowski, MD, FASAM, Medical Director, Addiction Psychiatry, MBH

Many patients can receive treatment for alcohol withdrawal safely in the community with the support of a primary care provider. This program will provide an overview of key elements and safety considerations of ambulatory alcohol withdrawal management programs.

Objectives:

Describe the role of ambulatory alcohol withdrawal management in the ASAM continuum of care.
Name 4 essential components of an ambulatory alcohol withdrawal management program.
Outline advantages and disadvantages of using benzodiazepines for ambulatory alcohol withdrawal management.